Mark Haigney, MD 

Mark Haigney, MD is a cardiologist and electrophysiologist who has practiced in the US Military Health System since completing fellowship. A former US Air Force officer, he is currently the Director of Cardiology at the Hebert School of Medicine in Bethesda, MD, and the Director of the Military Cardiovascular Outcomes Research (MiCOR) program. MiCOR is funded by the Defense Health Agency to address cardiac problems affecting men and women in the 18 to 45 year age group. Current projects include ECG screening of military recruits, genetic evaluation of military cardiac arrest victims, and the treatment of Postural Orthostatic Tachycardia Syndrome. He is co-chair of the 2025 ACC/AHA Scientific Statement "Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities.

Eugene Ho-Joon Chung, MD, MPH

Dr. Chung earned his AB at Harvard College, MSc at the University of Edinburgh, and MD at Jefferson Medical College (Philadelphia, PA). He then completed his residency in Internal Medicine, fellowship in Cardiovascular Medicine, and fellowship in Clinical Cardiac Electrophysiology (EP), all at the Lahey Clinic (Burlington, MA). In 2008, he joined the EP faculty at the University of North Carolina at Chapel Hill (UNC). While at UNC, he also served as UNC’s team cardiologist. In 2017, he was recruited to the University of Michigan (UM) to direct expansion of EP services in West Michigan for Michigan Medicine. He was also Director of the Sports Cardiology Clinic and Team Cardiologist for Michigan Athletics and several other universities and professional teams throughout Michigan. While at UM he was promoted to Clinical Professor and completed a Master in Public Health (MPH) in Population Health Science and a Certificate in Health Care Finance.  

Since joining Massachusetts General Hospital (MGH) in November 2023, Dr Chung continues to practice both clinical EP and sports cardiology. He is the inaugural Director of the Sports Electrophysiology Clinic in the Cardiovascular Performance Program (CPP), which provides comprehensive cardiovascular care for athletes and highly active individuals of all levels. He isTeam Cardiologist for Boston College Athletics and the Boston Fleet (PWHL). Nationally, he has been active in the Heart Rhythm Society (HRS) and American College of Cardiology (ACC), serving as Vice-Chair of the 2024 HRS consensus statement on arrhythmias in athletes and 2020-23 Chair of the ACC Sports and Exercise Cardiology Leadership Council. He is also Medical Director of the Sports Science and Safety Committee for USA Lacrosse.

Jonathan Ho-Youn Kim, MD, MSc, FACC, FAHA

Dr. Kim is a Professor of Medicine and Founding Director of Sports Cardiology in the Division of Cardiology at Emory University School of Medicine and additionally holds an adjunct Professorship in the School of Applied Physiology at the Georgia Institute of Technology. He received his Bachelor of Science at Emory and was a Fulbright Scholar before attending Vanderbilt Medical School. He completed his residency in Internal Medicine & Pediatrics at Massachusetts General Hospital and cardiology fellowship at Emory (chief fellow 2013-14). In addition to his clinical role, Dr. Kim conducts NIH-funded (current R01) sports cardiology research at Emory. He is the Team Cardiologist for the Atlanta Falcons, Braves, Hawks, United, and Dream, and for Sports Medicine at Emory and Georgia Tech. Dr. Kim consults for numerous other NCAA Division-I sports programs. Dr. Kim is a member of the NBA Cardiac Advisory Committee and NFL Cardiovascular Task Force. Dr. Kim is the immediate past-Chair of the American College of Cardiology’s Sports and Exercise Cardiology Council.

Rachel Lampert, MD

Dr. Lampert is the Robert Berliner Professor of Medicine in Cardiology/Electrophysiology, and Director of Sports Cardiology at Yale Medical School. Clinically, her focus is on care of athletes with potentially arrhythmogenic cardiovascular disorders, including athletes with implanted defibrillators, and identification through ECG screening. Her research interests include the impact of sports and exercise on arrhythmias in athletes with cardiovascular disease. She was the principle investigator for the ICD Sports Registry. Recent studies include the NIH-funded LIVE-HCM and LIVE-LQTS, parallel observational prospective registries looking at impact of vigorous exercise on arrhythmic outcomes, across the life-span from children to the middle-aged, in individuals with hypertrophic cardiomyopathy and the Long QT Syndrome. She serves on the steering committee of the ongoing ORCCA study. She is an author on professional society guidance documents from the Heart Rhythm Society, American College of Cardiology and American Heart Association, and serves on the ACC’s Sports and Exercise Council, as well as serving as a founding member of the Sports Cardiology Society. Dr Lampert went to medical school at Vanderbilt, then did residency and chief residency at Bellevue/NYU. She did cardiology and electrophysiology fellowship at Yale.

Benjamin D. Levine, MD, FACC, FAHA, FACSM

Benjamin D. Levine, M.D. is founder and Director of the Institute for Exercise and Environmental Medicine at Texas Health Presbyterian Hospital Dallas and a professor at UT Southwestern Medical Center. A Brown and Harvard graduate, he trained in internal medicine at Stanford and cardiology at UT Southwestern. Since founding IEEM in 1992, he has led pioneering research on how exercise, aging, and extreme environments affect cardiovascular function.

An internationally recognized sports cardiologist and space medicine expert, Dr. Levine advises major athletic organizations and has contributed to NASA and International Space Station research. He has received numerous national and international awards, published over 500 scientific works, and is a fellow and leader in multiple major medical and scientific societies.

Matthew Martinez, MD, FACC, FASE

Dr. Matthew W. Martinez is Enterprise Lead of Sports Cardiology for Mayo Clinic Foundation. Dr. Martinez serves as a cardiology consultant for Major League Soccer, the NBA players association and several other professional leagues and teams. He is an author on the Sports Cardiology Clinical consensus document and Hypertrophic Cardiomyopathy guidelines. He regularly presents on Sports Cardiology and Hypertrophic cardiomyopathy and is the prior Chair of American College of Cardiology’s Sports and Exercise section. He is one of the founders of the Sports Cardiology Society.

Silvana Molossi, MD, PhD

Dr. Molossi is an Associate Professor of Pediatrics, Division of Cardiology at Baylor College of Medicine and Associate Chief of Cardiology, the Heart Center at Texas Children’s Hospital. She graduated from the Federal University of Pelotas, Brazil, completed clinical and research fellowship in pediatric cardiology at the Hospital for Sick Children and received a doctorate degree in the departments of Pathology and Cardiovascular Sciences at the University of Toronto, Canada. She has been involved in screening athletes for >20 years, holds the Vice-President of Science and Research position for the Championship Hearts Foundation and is on the Medical Advisory Board for the National Coronary Anomalies Foundation, non-profit organizations. Dr. Molossi served as Co-Chair of the American College of Cardiology’s Sports and Exercise Cardiology Council from 2013-2016 and remains active within the Texas Chapter of the ACC. She is the Medical Director of the Coronary Artery Anomalies Program at Texas Children’s established in December 2012 and is the co-founder of the International Coronary Artery Anomalies Collaborative (ICAAC), an international team of experts furthering the knowledge in coronary artery anomalies. Dr. Molossi is also a founding member of the Sports Cardiology Society.

Dermot Phelan, MB, BAO, BCh, PhD, FASE, FACC

Dermot Phelan, MB, BAO, BCh, PhD, FASE, FACC is Professor of Cardiovascular Medicine at Wake Forest University School of Medicine and the Gragg Endowed Chair in Cardiovascular Medicine. He serves as Enterprise Lead of Cardiovascular Imaging and Director of both the Hypertrophic Cardiomyopathy (HCM) Center and the Gragg Center for Cardiovascular Performance at Advocate Health Sanger Heart & Vascular Institute in Charlotte, North Carolina.

Trained in cardiology in Ireland, Dr. Phelan completed advanced cardiac imaging fellowship training at the Cleveland Clinic, where he went on to establish and lead the institution’s first Sports Cardiology Center. His work focuses on distinguishing healthy athletic adaptation from heart disease, using advanced imaging to improve athlete safety and performance.

A recognized leader in sports cardiology, Dr. Phelan serves as the cardiology consultant for the NFL and MLB Scouting Combines, is Chair of the NFL Cardiovascular Task Force, and has been a member of the NBA Cardiovascular Advisory Committee since 2015. His team oversees cardiac imaging quality for the NBA, WNBA, and G League, reviewing more than 1,000 studies annually.

He has helped shape national guidelines for evaluating competitive athletes and is co-editor of Care of the Athletic Heart: From the Clinic to the Sidelines.